Browsing Tag
CORAL
3 posts
Entain (LSE: ENT) could sell SuperSport and STS exposure to cut £3.6bn debt
Entain is considering strategic options for its Central and Eastern European betting platform as higher UK gambling taxes, a heavily leveraged balance sheet and a depressed share price force management to reassess where capital can generate the strongest returns.
June 22, 2026
Entain (LSE: ENT) weighs Central Europe sale as UK gambling tax hit reshapes strategy
Entain is exploring options for its CEE unit as UK tax hikes, debt and a £488m impairment reshape ENT stock and gambling strategy.
June 19, 2026
Trevi Therapeutics (NASDAQ: TRVI) bets everything on two Phase 3 chronic cough trials
Trevi Therapeutics (NASDAQ: TRVI) has no revenue and is up 71%, yet its future rides on two Phase 3 cough trials that do not read out until 2027.
June 7, 2026